-
-
Boc-alpha-(3-chlorobenzyl)-DL-Pro-OH,≥96%(HPLC), 500mg
-
ethyl(2S)-1-benzylpyrrolidine-2-carboxylate,95%, 1g
-
ethyl(2S)-1-benzylpyrrolidine-2-carboxylate,95%, 5g
-
4-Amino-1-((R)-6-amino-2-((R)-2-((R)-2-((R)-2-amino-3-
phenylpropanamido)-3-
phenylpropanamido)-4-methylpentanamido)hexanoyl)piperidine-4-carboxylic acid trifluoroacetate,99%, 5mg
-
H-Arg-Pro-PRO-Gly-Phe-Ser-Pro-OH trifluoroacetate,99%, 50mg
-
(S)-2-((R)-2-((tert-Butoxycarbonyl)amino)-3-
phenylpropanamido)-3-
phenylpropanoic acid,97%, 100mg
-
(S)-2-((R)-2-((tert-Butoxycarbonyl)amino)-3-
phenylpropanamido)-3-
phenylpropanoic acid,97%, 250mg
-
Cathepsin D and E FRET Substrate,≥95%, 5mg
-
Corticotropin Releasing Factor Antagonist,≥95%(HPLC), 5mg
-
BI-9627,98%, 5mg
-
Adrenocorticotropic Hormone(ACTH)(18-39)， human TFA,≥99%, 5mg
стр.: